What is the level of liabilities of Embla Medical hf this year?
Embla Medical hf has a debt balance of 761.78 M USD this year.
Embla Medical hf Liabilities 2025
Embla Medical hf Liabilities
761.78 M USD
Ticker
EMBLA.CO
ISIN
IS0000000040
WKN
755122
In 2025, Embla Medical hf's total liabilities amounted to 761.78 M USD, a 11.4% difference from the 683.8 M USD total liabilities in the previous year.
Embla Medical hf Aktienanalyse
What does Embla Medical hf do?
Ossur hf is an Icelandic company specializing in the development and manufacturing of orthopedic products. The company was founded in 1971 by Orn Ragnarsson and has since brought many innovative products to the market. The company is headquartered in Reykjavik, Iceland, and operates in more than 30 countries worldwide. Furthermore, the company collaborates with partners and distributors from around the world. Ossur's products are intended for people with amputations, injuries, or chronic pain. Ossur's business model is to develop and manufacture high-quality, innovative solutions for the orthopedic industry. Ossur's products aim to improve the mobility, comfort, and quality of life for people with disabilities and injuries. Ossur operates in three main divisions: prosthetics, braces, and motion analysis. The prosthetics division focuses on the development of artificial limbs for people who have undergone amputation. The braces division focuses on the development of products such as knee braces, back braces, and ankle braces to support people with injuries or chronic pain. The motion analysis division focuses on the development of products such as motion measurement systems and gait analysis devices to assist orthopedic experts in diagnosing and treating patients. One of Ossur's most well-known products is the "Flex-Foot" leg prosthesis. The design of this prosthesis is based on the natural movements of a human foot and is a milestone in prosthetic development. Another innovative product from Ossur is the "Rheo" knee joint system, which is based on artificial intelligence and allows the user to walk more naturally. In recent years, Ossur has also expanded its product portfolio to the field of sports. The company has developed a range of products to help athletes improve their performance, avoid injuries, and heal faster. Overall, Ossur has shown in recent years that the company is always looking for new opportunities to develop innovative solutions in the field of orthopedics. Through a focus on research and development and collaboration with leading orthopedic experts, Ossur has established itself as a key player in the market. Embla Medical hf ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Embla Medical hf's Liabilities
Embla Medical hf's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Embla Medical hf's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Embla Medical hf's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Embla Medical hf's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Embla Medical hf’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Embla Medical hf stock
What were the liabilities of Embla Medical hf compared to the previous year?
The liabilities of Embla Medical hf have increased by 11.4% increased compared to the previous year.
What are the consequences of high debt for investors of Embla Medical hf?
High liabilities can pose a risk for investors of Embla Medical hf, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Embla Medical hf?
Low liabilities mean that Embla Medical hf has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Embla Medical hf affect the company?
An increase in liabilities of Embla Medical hf can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Embla Medical hf affect the company?
A decrease in the liabilities of Embla Medical hf can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Embla Medical hf?
Some factors that can influence the liabilities of Embla Medical hf include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Embla Medical hf so important for investors?
The liabilities of Embla Medical hf are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Embla Medical hf take to modify the liabilities?
To change its liabilities, Embla Medical hf can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Embla Medical hf pay?
Over the past 12 months, Embla Medical hf paid a dividend of 0.15 USD . This corresponds to a dividend yield of about 2.94 %. For the coming 12 months, Embla Medical hf is expected to pay a dividend of 1.74 USD.
What is the dividend yield of Embla Medical hf?
The current dividend yield of Embla Medical hf is 2.94 %.
When does Embla Medical hf pay dividends?
Embla Medical hf pays a quarterly dividend. This is distributed in the months of April, April, April, April.
How secure is the dividend of Embla Medical hf?
Embla Medical hf paid dividends every year for the past 6 years.
What is the dividend of Embla Medical hf?
For the upcoming 12 months, dividends amounting to 1.74 USD are expected. This corresponds to a dividend yield of 34.07 %.
In which sector is Embla Medical hf located?
Embla Medical hf is assigned to the 'Health' sector.
Wann musste ich die Aktien von Embla Medical hf kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Embla Medical hf from 3/26/2020 amounting to 0.15 USD, you needed to have the stock in your portfolio before the ex-date on 3/13/2020.
When did Embla Medical hf pay the last dividend?
The last dividend was paid out on 3/26/2020.
What was the dividend of Embla Medical hf in the year 2024?
In the year 2024, Embla Medical hf distributed 0 USD as dividends.
In which currency does Embla Medical hf pay out the dividend?
The dividends of Embla Medical hf are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Embla Medical hf
Our stock analysis for Embla Medical hf Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Embla Medical hf Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Embla Medical hf Revenue
- Embla Medical hf Net Income
- Embla Medical hf P/E
- Embla Medical hf P/S
- Embla Medical hf EBIT
- Embla Medical hf Dividend
- Embla Medical hf Stocks
- Embla Medical hf Market capitalization
- Embla Medical hf Debt
- Embla Medical hf Liabilities
- Embla Medical hf Equity
- Embla Medical hf AAQS
- Embla Medical hf Employees
- Embla Medical hf ROE
- Embla Medical hf ROA
- Embla Medical hf ROCE